Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-25 @ 3:04 PM
NCT ID:
NCT02073968
Group ID:
EG000
Title:
Treatment (PET-adjusted IMRT, Carboplatin, Paclitaxel)
Description:
RADIOTHERAPY: Patients undergo PET-adjusted IMRT or proton beam radiation therapy five days a week for 5 weeks.
CONCURRENT CHEMOTHERAPY: Patients receive carboplatin IV over 3 hours and paclitaxel IV over 1 hour once weekly for 6 weeks beginning week 1 of thoracic radiotherapy.
CONSOLIDATION CHEMOTHERAPY: Beginning approximately 4-6 weeks after the completion of all radiation therapy, patients may receive carboplatin IV over 30 minutes and paclitaxel IV over 3 hours on day 1. Treatment may repeat every 21 days for up to 3 courses in the absence of disease progression or unacceptable toxicity at the discretion of the treating physicians.
Carboplatin: Given IV
Intensity-Modulated Radiation Therapy: Undergo PET-adjusted IMRT
Paclitaxel: Given IV
Positron Emission Tomography: Undergo PET-adjusted IMRT
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
35
Other Number Affected:
35
Other Number At Risk:
35
Study:
NCT02073968
Results Section:
NCT02073968
Adverse Events Module:
NCT02073968